Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for helicobacter pylori eradication

Helicobacter

Volumn 14, Issue 5, 2009, Pages 449-459

  Zou, Jian ^a   Dong, Jie ^a   Yu, Xiaofeng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Eradication; H. pylori; Lactobacillus; Side effects

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; LACTOFERRIN; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROBIOTIC AGENT; RABEPRAZOLE; TINIDAZOLE;

ABDOMINAL PAIN; ARTICLE; BLOATING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; ERADICATION THERAPY; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LACTOBACILLUS; META ANALYSIS; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; SYSTEMATIC REVIEW; TASTE DISORDER;

HELICOBACTER PYLORI; LACTOBACILLUS;

EID: 70349132036     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00716.x     Document Type: Article

References (52)

1. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002 16 : 167 180.
2. Perri F, Qasim A, Marras L, et al. Treatment of Helicobacter pylori infection. Helicobacter 2003 8 (Suppl 1 53 60.
3. Urdaci M, Bressollier P, Pinchuk I. Bacillus clausii probiotic strains: antimicrobial and immunomodulatory activities. J Clin Gastroenterol 2004 38 (suppl 2 86 90.
4. Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J Nutr 2000 130 : 403 409.
5. Mitsuoka T. Significance of dietary modulation of intestinal flora and intestinal environment. Biosc Microflora 2000 19 : 15 25.
6. Michetti P. Lactobacilli for the management of Helicobacter pylori. Nutrition 2001 17 : 268 269.
7. Wendakoon CN, Thomson AB, Ozimek L. Lack of therapeutic effect of a specially designed yoghurt for the eradication of Helicobacter pylori infection. Digestion 2002 65 : 16 20.
8. Johnson C, Jimson H, Roos S. Anti Helicobacter pylori activity among lactic acid bacteria isolated from gastric biopsies and strains of Lactobacillus reuteri. Helicobacter 2003 8 : 473.
9. Johnson-Henry KC, Mitchell DJ, Avitzur Y, et al. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci 2004 49 : 1095 1102.
10. Gotteland M, Andrews M, Toledo M, et al. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nurition 2008 24 (5 421 426.
11. Francavilla R, Lionetti E, Castellaneta SP, et al. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter 2008 13 (2 127 134.
12. Imase K, Tanaka A, Tokunaga K, et al. Lactobacillus reuteri tablets suppress Helicobacter pylori infection-a double-blind randomized placebo-controlled cross-over clinical study. Kansenshogaku Zasshi 2007 81 (4 387 393.
13. Goldman CG, Barrado DA, Balcarce N, et al. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 2006 22 (10 984 988.
14. Pantoflickova D, Corthésy-Theulaz I, Dorta G, et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis. Aliment Pharmacol Ther 2003 18 (8 805 813.
15. Cruchet S, Obregon MC, Salazar G, et al. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 2003 19 (9 716 721. (Pubitemid 36961381)
16. Cats A, Kuipers EJ, Bosschaert MA, et al. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther 2003 17 (3 429 435.
17. Felley CP, Corthésy-Theulaz I, Rivero JL, et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 2001 13 (1 25 9.
18. Michetti P, Dorta G, Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999 60 (3 203 209.
19. Eremina EIu, Bondarenko VM, Zvereva SI, et al. Dysbiotic manifestations during eradication therapy of Helicobacter pylori and their corrections. Zh Mikrobiol Epidemiol Immunobiol 2008 3 : 62 6.
20. Myllyluoma E, Ahlroos T, Veijola L, et al. Effects of anti- Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. Int J Antimicrob Agents 2007 29 (1 66 72.
21. Sheu BS, Cheng HC, Kao AW, et al. Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr 2006 83 (4 864 869.
22. Myllyluoma E, Veijola L, Ahlroos T, et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy-a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther 2005 21 (10 1263 1272.
23. Sheu BS, Wu JJ, Lo CY, et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002 16 (9 1669 1675.
24. Gotteland M, Poliak L, Cruchet S, et al. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Acta Paediatr 2005 94 (12 1747 1751.
25. Wang KY, Li SN, Liu CS, et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004 80 (3 737 741.
26. Linsalata M, Russo F, Berloco P, et al. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 2004 9 (2 165 172.
27. Lionetti E, Miniello VL, Castellaneta SP, et al. Lactobacillus reuteri therapy to reduce side-effects during anti- Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 2006 24 (10 1461 1468.
28. San YJ, Cao CY, Li SC, et al. Triple therapy and bifid triple viable capsule as sequential therapy for H. pylori eradication treatment. Zhejiang Prev Med 2008 20 (9 79 80.
29. Tursi A, Brandimarte G, Giorgetti GM, et al. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit 2004 10 (12 662 666.
30. Wang XY, Zhang YL, He YL, et al. Clinical Study Of Supplementation Lactobacillus acidophilus on lansoprazole amoxycillin and clarithromycin triple therapy regimens for persistent Helicobacter pylori infection. J Qiqihar Med College 2007 28 (16 1927 1929.
31. Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001 15 (2 163 169. (Pubitemid 32142492)
32. Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001 63 (1 1 7. (Pubitemid 32098452)
33. Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000 14 (12 1625 1629.
34. Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti- Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002 97 (11 2744 2749.
35. Giovannone M, Barberani F, Boschetto S, et al. Lactobacillus casei Dg effectiveness on Helicobacter pylori eradication treatment-side effects; A placebo-controlled, double-blind randomized pilot study. Gastroenterology 2007 132 (4 Suppl 2 A614.
36. Scaccianoce G, Zullo A, Hassan C, et al. Triple therapies plus different probiotics for Helicobacter pylori eradication. Eur Rev Med Pharmacol Sci 2008 12 (4 251 256.
37. Sýkora J, Valecková K, Amlerová J, et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005 39 (8 692 698.
38. Sahagún-Flores JE, López-Peña LS, de la Cruz-Ramírez Jaimes J, et al. Eradication of Helicobacter pylori: triple treatment scheme plus Lactobacillus vs. triple treatment alone. Cir Cir 2007 75 (5 333 336.
39. Ziemniak W. Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics. J Physiol Pharmacol 2006 57 (Suppl 3 123 141.
40. Tong JL, Ran ZH, Shen J, et al. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007 25 (2 155 168.
41. Lewis SJ, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998 12 : 807 822.
42. Chauviere G, Coconnier MH, Karneis S, et al. Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat killed Lactobacillus. FEMS Microbiol Lett 1992 91 : 213 218.
43. Coconnier MH, Lievin V, Hemery E, et al. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998 64 : 4573 4580.
44. Oozeer R, Goupill-Feuillerat N, Alpert CA, et al. Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora associated mice. Appl Environ Microbiol 2002 68 : 3570 3574.
45. Vilaichone RK, Mahachai V, Tumwasorn S, et al. Inhibitory effect of lactobacillus acidophilus on Helicobacter pylori in peptic ulcer patients: in vitro study. J Med Assoc Thai 2002 85 (suppl l 79 84.
46. Cats A, Kuipers EJ, Bosschaert MA, et al. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonised subjects. Aliment Pharmacol Ther 2003 17 : 429 435.
47. Kabir AM, Aiba Y, Takagi A, et al. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murinemodel. Gut 1997 41 : 49 55.
48. Canducci F, Cremonini F, Armuzzi A, et al. Probiotics and Helicobacter pylori eradication. Dig Liver Dis 2002 34 (suppl 81 3.
49. Midolo PD, Lambert JR, Hull R, et al. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 1995 79 : 475 479.
50. Michetti P, Dorta G, Weisel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonni) La1 on Helicobacter pylori infection in humans. Digestion 1999 60 : 203 209.
51. Ushiyma A, Tanaka K, Aiba Y, et al. Lactobacillus gasseri OLL2716 as a probiotic in clarithromycine-resistant Helicobacter pylori infection. J Gastroenterol Hepatol 2003 18 : 986 991.
52. Altintas E, Sezgin O, Ulu O, et al. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. World J Gastroenterol 2004 10 : 1656 1658.